选择性腹腔大动脉动脉瘤修复后的他类药物治疗改善了长期生存率
Fredrik Lilja1, Anders Wanhainen1,2, Kevin Mani1
1Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
The British journal of surgery
|January 10, 2024
概括
手术后的他类药物治疗显著改善了腹腔大动脉瘤修复的患者的长期存活率. 然而,手术前使用他类药物和高强度他类药物治疗并没有提供额外的生存益处.
科学领域:
- 心血管外科心血管外科
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 患有腹腔大动脉动脉瘤的患者面临高心血管事件风险.
- 对于这些患者来说,他类药物治疗是标准的,但最佳强度尚不清楚.
- 研究他类药物治疗对腹腔大动脉瘤修复后生存的影响至关重要.
研究的目的:
- 为了评估他类药物治疗对接受腹腔大动脉瘤修复的患者的生存的影响.
- 为了比较高强度与中低强度的他类药物治疗的长期存活.
主要方法:
- 利用全国性的瑞典登记 (2006-2018) 医院入院,手术和药物.
- 雇员倾向性得分在三个队列中匹配:术前死亡率,长期存活率 (术后使用他类药物) 和他类药物的强度.
主要成果:
- 术前使用他类药物并没有降低90天术后死亡率.
- 手术后使用他类药物与明显改善的长期存活率有关.
- 高强度他类药物治疗在长期存活方面没有比中低强度疗法有任何优势.
结论:
- 手术后使用他类药物治疗显著提高了腹腔大动脉动脉瘤修复后的长期存活率.
- 在手术前使用他类药物没有为外科手术后的生存带来好处.
- 与较低强度相比,高强度他类药物治疗没有观察到额外的生存益处.
相关概念视频
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...


